Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Clear all filters
Clear all filters
Travere Therapeutics Inc.
US$175m
February 2021

Travere Therapeutics Inc.

Lead Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Kaledio
US$69m
February 2021

Kaledio

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Bioventus Inc.
US$120m
February 2021

Bioventus Inc.

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Rhythm Pharmaceuticals, Inc.
US$173m
February 2021

Rhythm Pharmaceuticals, Inc.

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Adicet Bio, Inc.
US$138m
February 2021

Adicet Bio, Inc.

Co-Manager (CMPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Quanterix Corporation
US$250m
February 2021

Quanterix Corporation

Lead Manager (CMPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Sundial Growers, Inc.
US$75m
February 2021

Sundial Growers, Inc.

Sole Bookrunner (Follow-on)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Neuronetics, Inc.
US$75m
January 2021

Neuronetics, Inc.

Lead Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
Marketware
January 2021

Marketware

Exclusive Financial Advisor to Marketware on its acquisition by Medsphere Systems Corporation
/490e79/globalassets/capital-markets/images/transaction-logos/medsphere-systems-corporation-sales-logo.png
HEALTHCARE TECHNOLOGY FINANCIAL SPONSORS M&A ADVISORY US
View transaction detail
Mavens
January 2021

Mavens

Financial Advisor to Mavens on sale to Komodo Health, a portfolio company of ICONIQ
/491150/globalassets/capital-markets/images/transaction-logos/komodo.png
TECHNOLOGY HEALTHCARE M&A ADVISORY US
View transaction detail
Columbia Care
C$130m
January 2021

Columbia Care

Lead Bookrunner (Bought Deal)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS US
Curaleaf
US$275m
January 2021

Curaleaf

Lead Bookrunner (Overnight Marketed)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS US

Here to support you...

  1. Company information as at 31 March 2019
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description